_id
69105757ccc777a4e85d567f
Ticker
CVALF
Name
Covalon Technologies Ltd
Exchange
OTCQX
Address
1660 Tech Avenue, Mississauga, ON, Canada, L4W 5S7
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://covalon.com
Description
Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, the Middle East, Canada, Latin America, Asia, and internationally. The company's platform technologies comprises collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre- and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone. It also offers a medical coating platform, a process that utilizes photo-polymerization to create active grafting sites where new polymer chains are initiated and propagated from the surface of an existing medical device. In addition, the company provides advanced wound care, antimicrobial dressings, collagen dressings, IV dressings, perioperative dressings, silicone dressings, vascular access line guards, and wound dressings; and surgical, peri-operative, and infection management products. It sells its products directly and through independent distributors under the ColActive, ColActive PLUS, CovaWound, CovaView, CovaClear IV, IV Clear, SurgiClear, MediClear, and VALGuard brands. The company serves health care providers, such as hospitals, wound care centers, burn centers, extended/alternate care facilities, acute care facilities, home health care agencies, and physicians' offices. Covalon Technologies Ltd. is headquartered in Mississauga, Canada.
Last Close
1.25
Volume
2100
Current Price
1.34
Change
0.02
Last Updated
2026-01-02T12:13:55.116Z
Image
data:image/webp;base64,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
Ipo Date
-
Market Cap
34352900
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0
Sentiment Sources
1
Rating
4
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
8691972
Cost Of Revenue
4246575
Gross Profit
4445397
Operating Expenses
8446126
Operating Income
245846
Interest Expense
-
Pretax Income
358337
Net Income
358337
Eps
0.013069370255251673
Dividends Per Share
-
Shares Outstanding
27418077
Income Tax Expense
-
EBITDA
-
Operating Margin
2.8284260464713875
Total Other Income Expense Net
0
Cash
17367288
Short Term Investments
-
Receivables
5840217
Inventories
7400787
Total Current Assets
31530850
Property Plant Equipment
3242063
Total Assets
36123587
Payables
-
Short Term Debt
-
Long Term Debt
-
Total Liabilities
5396678
Equity
30726909
Bs_currency_symbol
CAD
Depreciation
248144
Change In Working Capital
-1371972
Cash From Operations
-667211
Capital Expenditures
180214
Cash From Investing
-
Cash From Financing
-182037
Net Change In Cash
-723490
Cf_currency_symbol
CAD
PE
24.8
PB
1.1957018904830292
ROE
1.1661993075841113
ROA
0.9919751324806145
FCF
-847425
Fcf Percent
-0.09749513689183537
Piotroski FScore
2
Health Score
51
Deep Value Investing Score
6.5
Defensive Investing Score
5
Dividend Investing Score
1.5
Economic Moat Investing Score
5.8
Garp Investing Score
5
Growth Investing Score
3.5
Momentum Investing Score
6.5
Net Net Investing Score
3.5
Quality Investing Score
3
Value Investing Score
6
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
8691972
Quarters > 0 > income Statement > cost Of Revenue
4246575
Quarters > 0 > income Statement > gross Profit
4445397
Quarters > 0 > income Statement > operating Expenses
8446126
Quarters > 0 > income Statement > operating Income
245846
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
358337
Quarters > 0 > income Statement > net Income
358337
Quarters > 0 > income Statement > eps
0.013069370255251673
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
27418077
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
2.8284260464713875
Quarters > 0 > income Statement > total Other Income Expense Net
-
Quarters > 0 > income Statement > currency_symbol
CAD
Quarters > 0 > balance Sheet > cash
17367288
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
5840217
Quarters > 0 > balance Sheet > inventories
7400787
Quarters > 0 > balance Sheet > total Current Assets
31530850
Quarters > 0 > balance Sheet > property Plant Equipment
3242063
Quarters > 0 > balance Sheet > total Assets
36123587
Quarters > 0 > balance Sheet > payables
-
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
5396678
Quarters > 0 > balance Sheet > equity
30726909
Quarters > 0 > balance Sheet > currency_symbol
CAD
Quarters > 0 > cash Flow > net Income
358337
Quarters > 0 > cash Flow > depreciation
248144
Quarters > 0 > cash Flow > change In Working Capital
-1371972
Quarters > 0 > cash Flow > cash From Operations
-667211
Quarters > 0 > cash Flow > capital Expenditures
180214
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-182037
Quarters > 0 > cash Flow > net Change In Cash
-723490
Quarters > 0 > cash Flow > currency_symbol
CAD
Quarters > 0 > ratios > PE
0.013069370255251673
Quarters > 0 > ratios > PB
1.1957018904830292
Quarters > 0 > ratios > ROE
1.1661993075841113
Quarters > 0 > ratios > ROA
0.9919751324806145
Quarters > 0 > ratios > FCF
-847425
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
-0.09749513689183537
Quarters > 0 > health Score
51
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
8372427
Quarters > 1 > income Statement > cost Of Revenue
4479932
Quarters > 1 > income Statement > gross Profit
3892495
Quarters > 1 > income Statement > operating Expenses
8451089
Quarters > 1 > income Statement > operating Income
-78662
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
64567
Quarters > 1 > income Statement > net Income
64567
Quarters > 1 > income Statement > eps
0.002354906217529406
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
27418077
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-0.9395364092156312
Quarters > 1 > income Statement > total Other Income Expense Net
-
Quarters > 1 > income Statement > currency_symbol
CAD
Quarters > 1 > balance Sheet > cash
18090778
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
4595603
Quarters > 1 > balance Sheet > inventories
8055970
Quarters > 1 > balance Sheet > total Current Assets
31731618
Quarters > 1 > balance Sheet > property Plant Equipment
2160643
Quarters > 1 > balance Sheet > total Assets
35236960
Quarters > 1 > balance Sheet > payables
-
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
5559015
Quarters > 1 > balance Sheet > equity
29677945
Quarters > 1 > balance Sheet > currency_symbol
CAD
Quarters > 1 > cash Flow > net Income
64567
Quarters > 1 > cash Flow > depreciation
216053
Quarters > 1 > cash Flow > change In Working Capital
1811024
Quarters > 1 > cash Flow > cash From Operations
2156791
Quarters > 1 > cash Flow > capital Expenditures
442120
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
-149622
Quarters > 1 > cash Flow > net Change In Cash
60214
Quarters > 1 > cash Flow > currency_symbol
CAD
Quarters > 1 > ratios > PE
0.002354906217529406
Quarters > 1 > ratios > PB
1.2379638543032547
Quarters > 1 > ratios > ROE
0.21755886399816426
Quarters > 1 > ratios > ROA
0.18323657886491912
Quarters > 1 > ratios > FCF
1714671
Quarters > 1 > ratios > Piotroski FScore
4
Quarters > 1 > ratios > fcf Percent
0.2047997551964323
Quarters > 1 > health Score
70
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
7585968
Quarters > 2 > income Statement > cost Of Revenue
3446462
Quarters > 2 > income Statement > gross Profit
4139506
Quarters > 2 > income Statement > operating Expenses
7304148
Quarters > 2 > income Statement > operating Income
281820
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
429139
Quarters > 2 > income Statement > net Income
429139
Quarters > 2 > income Statement > eps
0.015651681188290485
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
27418077
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
3.71501698926228
Quarters > 2 > income Statement > total Other Income Expense Net
-
Quarters > 2 > income Statement > currency_symbol
CAD
Quarters > 2 > balance Sheet > cash
18030564
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
4872199
Quarters > 2 > balance Sheet > inventories
8930379
Quarters > 2 > balance Sheet > total Current Assets
32612248
Quarters > 2 > balance Sheet > property Plant Equipment
1086003
Quarters > 2 > balance Sheet > total Assets
35146627
Quarters > 2 > balance Sheet > payables
-
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
3996672
Quarters > 2 > balance Sheet > equity
31149955
Quarters > 2 > balance Sheet > currency_symbol
CAD
Quarters > 2 > cash Flow > net Income
429139
Quarters > 2 > cash Flow > depreciation
233621
Quarters > 2 > cash Flow > change In Working Capital
-61750
Quarters > 2 > cash Flow > cash From Operations
675095
Quarters > 2 > cash Flow > capital Expenditures
32568
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
-81642
Quarters > 2 > cash Flow > net Change In Cash
532957
Quarters > 2 > cash Flow > currency_symbol
CAD
Quarters > 2 > ratios > PE
0.015651681188290485
Quarters > 2 > ratios > PB
1.179463122177865
Quarters > 2 > ratios > ROE
1.3776552807219142
Quarters > 2 > ratios > ROA
1.2209962566251378
Quarters > 2 > ratios > FCF
642527
Quarters > 2 > ratios > Piotroski FScore
4
Quarters > 2 > ratios > fcf Percent
0.08469940817045365
Quarters > 2 > health Score
60
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
8165980
Quarters > 3 > income Statement > cost Of Revenue
3171514
Quarters > 3 > income Statement > gross Profit
4994466
Quarters > 3 > income Statement > operating Expenses
6851312
Quarters > 3 > income Statement > operating Income
1314668
Quarters > 3 > income Statement > interest Expense
149690
Quarters > 3 > income Statement > pretax Income
1206046
Quarters > 3 > income Statement > net Income
1206046
Quarters > 3 > income Statement > eps
0.04401936676066718
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
27398077
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
16.099329168085152
Quarters > 3 > income Statement > total Other Income Expense Net
-
Quarters > 3 > income Statement > currency_symbol
CAD
Quarters > 3 > balance Sheet > cash
17497607
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
5356596
Quarters > 3 > balance Sheet > inventories
8570914
Quarters > 3 > balance Sheet > total Current Assets
32047023
Quarters > 3 > balance Sheet > property Plant Equipment
1199710
Quarters > 3 > balance Sheet > total Assets
34816921
Quarters > 3 > balance Sheet > payables
-
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
4165290
Quarters > 3 > balance Sheet > equity
30651631
Quarters > 3 > balance Sheet > currency_symbol
CAD
Quarters > 3 > cash Flow > net Income
1206046
Quarters > 3 > cash Flow > depreciation
257125
Quarters > 3 > cash Flow > change In Working Capital
-1588593
Quarters > 3 > cash Flow > cash From Operations
124531
Quarters > 3 > cash Flow > capital Expenditures
192122
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-116045
Quarters > 3 > cash Flow > net Change In Cash
750826
Quarters > 3 > cash Flow > currency_symbol
CAD
Quarters > 3 > ratios > PE
0.04401936676066718
Quarters > 3 > ratios > PB
1.1977640987522002
Quarters > 3 > ratios > ROE
3.9346878474427673
Quarters > 3 > ratios > ROA
3.4639651220163894
Quarters > 3 > ratios > FCF
-67591
Quarters > 3 > ratios > Piotroski FScore
3
Quarters > 3 > ratios > fcf Percent
-0.008277144935451716
Quarters > 3 > health Score
57
Annuals > 0 > quarter
2025-09-30
Annuals > 0 > income Statement > revenue
32816347
Annuals > 0 > income Statement > cost Of Revenue
15344483
Annuals > 0 > income Statement > gross Profit
17471864
Annuals > 0 > income Statement > operating Expenses
31052675
Annuals > 0 > income Statement > operating Income
1763672
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
2058089
Annuals > 0 > income Statement > net Income
2058089
Annuals > 0 > income Statement > eps
0.07506321468132138
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
27418077
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
5.374370279543911
Annuals > 0 > income Statement > total Other Income Expense Net
-149690
Annuals > 0 > income Statement > currency_symbol
CAD
Annuals > 0 > balance Sheet > cash
17367288
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
5840217
Annuals > 0 > balance Sheet > inventories
7400787
Annuals > 0 > balance Sheet > total Current Assets
31530850
Annuals > 0 > balance Sheet > property Plant Equipment
3242063
Annuals > 0 > balance Sheet > total Assets
36123587
Annuals > 0 > balance Sheet > payables
-
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
5396678
Annuals > 0 > balance Sheet > equity
30726909
Annuals > 0 > balance Sheet > currency_symbol
CAD
Annuals > 0 > cash Flow > net Income
2058089
Annuals > 0 > cash Flow > depreciation
954943
Annuals > 0 > cash Flow > change In Working Capital
-1211291
Annuals > 0 > cash Flow > cash From Operations
2289206
Annuals > 0 > cash Flow > capital Expenditures
847024
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
-529346
Annuals > 0 > cash Flow > net Change In Cash
620507
Annuals > 0 > cash Flow > currency_symbol
CAD
Annuals > 0 > ratios > PE
0.07506321468132138
Annuals > 0 > ratios > PB
1.0707778123728617
Annuals > 0 > ratios > ROE
6.698002067178316
Annuals > 0 > ratios > ROA
5.697355027339893
Annuals > 0 > ratios > FCF
1442182
Annuals > 0 > ratios > Piotroski FScore
4
Annuals > 0 > ratios > fcf Percent
0.043947060896205176
Annuals > 0 > health Score
65
Annuals > 1 > quarter
2024-09-30
Annuals > 1 > income Statement > revenue
31168532
Annuals > 1 > income Statement > cost Of Revenue
12235807
Annuals > 1 > income Statement > gross Profit
18932725
Annuals > 1 > income Statement > operating Expenses
29017499
Annuals > 1 > income Statement > operating Income
2151033
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
2669792
Annuals > 1 > income Statement > net Income
2669792
Annuals > 1 > income Statement > eps
0.09744450313063942
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
27398077
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
6.901297115950151
Annuals > 1 > income Statement > total Other Income Expense Net
610008
Annuals > 1 > income Statement > currency_symbol
CAD
Annuals > 1 > balance Sheet > cash
16746781
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
3645252
Annuals > 1 > balance Sheet > inventories
7696084
Annuals > 1 > balance Sheet > total Current Assets
29038951
Annuals > 1 > balance Sheet > property Plant Equipment
1179181
Annuals > 1 > balance Sheet > total Assets
31806574
Annuals > 1 > balance Sheet > payables
-
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
4301966
Annuals > 1 > balance Sheet > equity
27504608
Annuals > 1 > balance Sheet > currency_symbol
CAD
Annuals > 1 > cash Flow > net Income
2669792
Annuals > 1 > cash Flow > depreciation
986458
Annuals > 1 > cash Flow > change In Working Capital
-290979
Annuals > 1 > cash Flow > cash From Operations
3472985
Annuals > 1 > cash Flow > capital Expenditures
416835
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
4972062
Annuals > 1 > cash Flow > net Change In Cash
7952131
Annuals > 1 > cash Flow > currency_symbol
CAD
Annuals > 1 > ratios > PE
0.09744450313063942
Annuals > 1 > ratios > PB
1.1953521533555396
Annuals > 1 > ratios > ROE
9.706708054155872
Annuals > 1 > ratios > ROA
8.393837072801364
Annuals > 1 > ratios > FCF
3056150
Annuals > 1 > ratios > Piotroski FScore
4
Annuals > 1 > ratios > fcf Percent
0.09805242030648091
Annuals > 1 > health Score
75
Annuals > 2 > quarter
2023-09-30
Annuals > 2 > income Statement > revenue
26595286
Annuals > 2 > income Statement > cost Of Revenue
12233447
Annuals > 2 > income Statement > gross Profit
14361839
Annuals > 2 > income Statement > operating Expenses
31123786
Annuals > 2 > income Statement > operating Income
-4528500
Annuals > 2 > income Statement > interest Expense
-
Annuals > 2 > income Statement > pretax Income
-4460998
Annuals > 2 > income Statement > net Income
-4460998
Annuals > 2 > income Statement > eps
-0.1808299347816138
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
24669577
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-
Annuals > 2 > income Statement > operating Margin
-17.02745366227684
Annuals > 2 > income Statement > total Other Income Expense Net
-
Annuals > 2 > income Statement > currency_symbol
CAD
Annuals > 2 > balance Sheet > cash
8794650
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
6162069
Annuals > 2 > balance Sheet > inventories
5944534
Annuals > 2 > balance Sheet > total Current Assets
21291313
Annuals > 2 > balance Sheet > property Plant Equipment
1682775
Annuals > 2 > balance Sheet > total Assets
24900593
Annuals > 2 > balance Sheet > payables
-
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
6107776
Annuals > 2 > balance Sheet > equity
18792817
Annuals > 2 > balance Sheet > currency_symbol
CAD
Annuals > 2 > cash Flow > net Income
-4461000
Annuals > 2 > cash Flow > depreciation
969370
Annuals > 2 > cash Flow > change In Working Capital
-317748
Annuals > 2 > cash Flow > cash From Operations
-3184008
Annuals > 2 > cash Flow > capital Expenditures
1316517
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
-2156054
Annuals > 2 > cash Flow > net Change In Cash
-5266981
Annuals > 2 > cash Flow > currency_symbol
CAD
Annuals > 2 > ratios > PE
-0.1808299347816138
Annuals > 2 > ratios > PB
1.575255716053639
Annuals > 2 > ratios > ROE
-23.73778236652866
Annuals > 2 > ratios > ROA
-17.9152279626433
Annuals > 2 > ratios > FCF
-4500525
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-0.16922265848165724
Annuals > 2 > health Score
34
Annuals > 3 > quarter
2022-09-30
Annuals > 3 > income Statement > revenue
18146390
Annuals > 3 > income Statement > cost Of Revenue
10652885
Annuals > 3 > income Statement > gross Profit
7493505
Annuals > 3 > income Statement > operating Expenses
27288718
Annuals > 3 > income Statement > operating Income
-9142328
Annuals > 3 > income Statement > interest Expense
111590
Annuals > 3 > income Statement > pretax Income
-9253918
Annuals > 3 > income Statement > net Income
-9663213
Annuals > 3 > income Statement > eps
-0.38212979337804187
Annuals > 3 > income Statement > dividends Per Share
0
Annuals > 3 > income Statement > shares Outstanding
25287777
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-8109520
Annuals > 3 > income Statement > operating Margin
-50.38097384658877
Annuals > 3 > income Statement > total Other Income Expense Net
-
Annuals > 3 > income Statement > currency_symbol
CAD
Annuals > 3 > balance Sheet > cash
14061631
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
4732430
Annuals > 3 > balance Sheet > inventories
4965668
Annuals > 3 > balance Sheet > total Current Assets
27228057
Annuals > 3 > balance Sheet > property Plant Equipment
1872697
Annuals > 3 > balance Sheet > total Assets
30378081
Annuals > 3 > balance Sheet > payables
3720208
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
6149320
Annuals > 3 > balance Sheet > equity
24228761
Annuals > 3 > balance Sheet > currency_symbol
CAD
Annuals > 3 > cash Flow > net Income
-9663213
Annuals > 3 > cash Flow > depreciation
923252
Annuals > 3 > cash Flow > change In Working Capital
-83384
Annuals > 3 > cash Flow > cash From Operations
-8378310
Annuals > 3 > cash Flow > capital Expenditures
599844
Annuals > 3 > cash Flow > cash From Investing
315298
Annuals > 3 > cash Flow > cash From Financing
-2271197
Annuals > 3 > cash Flow > net Change In Cash
-8885292
Annuals > 3 > cash Flow > currency_symbol
CAD
Annuals > 3 > ratios > PE
-0.38212979337804187
Annuals > 3 > ratios > PB
1.252450853760124
Annuals > 3 > ratios > ROE
-39.8832321636257
Annuals > 3 > ratios > ROA
-31.809820376738084
Annuals > 3 > ratios > FCF
-8978154
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-0.4947625395464332
Annuals > 3 > health Score
34
Valuation > metrics > PE
24.8
Valuation > metrics > PB
1.1957018904830292
Valuation > final Score
100
Valuation > verdict
Fair
Profitability > metrics > ROE
1.1661993075841113
Profitability > metrics > ROA
1.1364647638741106
Profitability > metrics > Net Margin
0.04122620275352935
Profitability > final Score
12
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.1756336115682837
Risk > final Score
80
Risk > verdict
Low
Liquidity > final Score
50
Liquidity > verdict
Weak
Prev Valuations > 0
100
Prev Valuations > 1
100
Prev Valuations > 2
100
Prev Profitabilities > 0
2
Prev Profitabilities > 1
15
Prev Profitabilities > 2
41
Prev Risks > 0
80
Prev Risks > 1
80
Prev Risks > 2
95
Prev Liquidities > 0
50
Prev Liquidities > 1
50
Prev Liquidities > 2
50
Updated At
2026-01-20T21:40:43.848Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-09-30
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0.01
Earnings History > 0 > eps Estimate
-0.04
Earnings History > 0 > eps Difference
0.05
Earnings History > 0 > surprise Percent
125
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-06-30
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0
Earnings History > 1 > eps Estimate
0.04
Earnings History > 1 > eps Difference
-0.04
Earnings History > 1 > surprise Percent
-100
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-03-31
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
0.02
Earnings History > 2 > eps Estimate
0.01
Earnings History > 2 > eps Difference
0.01
Earnings History > 2 > surprise Percent
100
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-02-26
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
CAD
Earnings History > 3 > eps Actual
0.035
Earnings History > 3 > eps Estimate
-0.03
Earnings History > 3 > eps Difference
0.065
Earnings History > 3 > surprise Percent
216.6667
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-09-30
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
0.0199
Earnings History > 4 > eps Estimate
0.05
Earnings History > 4 > eps Difference
-0.0301
Earnings History > 4 > surprise Percent
-60.2
Earnings History > 5 > period
2021-06-30
Earnings History > 5 > report Date
2021-08-30
Earnings History > 5 > date
2021-06-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
CAD
Earnings History > 5 > eps Actual
0.0311
Earnings History > 5 > eps Estimate
-0.02
Earnings History > 5 > eps Difference
0.0511
Earnings History > 5 > surprise Percent
255.5
Earnings History > 6 > period
2021-03-31
Earnings History > 6 > report Date
2021-05-31
Earnings History > 6 > date
2021-03-31
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
CAD
Earnings History > 6 > eps Actual
0.0323
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
0.0323
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2020-12-31
Earnings History > 7 > report Date
2021-03-01
Earnings History > 7 > date
2020-12-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
CAD
Earnings History > 7 > eps Actual
0.013
Earnings History > 7 > eps Estimate
0
Earnings History > 7 > eps Difference
0.013
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2020-09-30
Earnings History > 8 > report Date
2020-12-31
Earnings History > 8 > date
2020-09-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
CAD
Earnings History > 8 > eps Actual
-0.0113
Earnings History > 8 > eps Estimate
0
Earnings History > 8 > eps Difference
-0.0113
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2020-06-30
Earnings History > 9 > report Date
2020-07-14
Earnings History > 9 > date
2020-06-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
CAD
Earnings History > 9 > eps Actual
-0.0676
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
-0.0676
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2020-03-31
Earnings History > 10 > report Date
2020-06-30
Earnings History > 10 > date
2020-03-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
CAD
Earnings History > 10 > eps Actual
0.0074
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
0.0074
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2019-12-31
Earnings History > 11 > report Date
2020-03-02
Earnings History > 11 > date
2019-12-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
CAD
Earnings History > 11 > eps Actual
-0.1076
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
-0.1076
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2019-09-30
Earnings History > 12 > report Date
2019-12-31
Earnings History > 12 > date
2019-09-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
CAD
Earnings History > 12 > eps Actual
-0.0385
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
-0.0385
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2019-06-30
Earnings History > 13 > report Date
2019-08-27
Earnings History > 13 > date
2019-06-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
CAD
Earnings History > 13 > eps Actual
-0.16
Earnings History > 13 > eps Estimate
-0.02
Earnings History > 13 > eps Difference
-0.14
Earnings History > 13 > surprise Percent
-700
Earnings History > 14 > period
2019-03-31
Earnings History > 14 > report Date
2019-05-28
Earnings History > 14 > date
2019-03-31
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
CAD
Earnings History > 14 > eps Actual
-0.0074
Earnings History > 14 > eps Estimate
-0.03
Earnings History > 14 > eps Difference
0.0226
Earnings History > 14 > surprise Percent
75.3333
Earnings History > 15 > period
2006-12-31
Earnings History > 15 > report Date
2007-01-26
Earnings History > 15 > date
2006-12-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
CAD
Earnings History > 15 > eps Actual
-0.2
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
-0.2
Earnings History > 15 > surprise Percent
-
Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, the Middle East, Canada, Latin America, Asia, and internationally. The company's platform technologies comprises collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre- and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone. It also offers a medical coating platform, a process that utilizes photo-polymerization to create active grafting sites where new polymer chains are initiated and propagated from the surface of an existing medical device. In addition, the company provides advanced wound care, antimicrobial dressings, collagen dressings, IV dressings, perioperative dressings, silicone dressings, vascular access line guards, and wound dressings; and surgical, peri-operative, and infection management products. It sells its products directly and through independent distributors under the ColActive, ColActive PLUS, CovaWound, CovaView, CovaClear IV, IV Clear, SurgiClear, MediClear, and VALGuard brands. The company serves health care providers, such as hospitals, wound care centers, burn centers, extended/alternate care facilities, acute care facilities, home health care agencies, and physicians' offices. Covalon Technologies Ltd. is headquartered in Mississauga, Canada.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ACovalon Technologies (OTCMKTS:CVALF) Shares Up 10.5% – What’s Next? Defense World
Read more →Covalon Technologies Ltd (CVALF) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic ... Yahoo Finance
Read more →Showing 2 of 9
(Last Updated 2025-09-30)
Rating:
BUY
$
Analyst Picks
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Neutral
(Last Updated 2025-09-30)
Health Score
Price to Earnings Ratio (P/E)
-
High
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Covalon Technologies Ltd
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
0.01
EPS Estimate
-0.04
EPS Difference
0.05
Surprise Percent
125%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.